Abstract
A new study calls for further investigation into the potential benefits and risks of COX-2 specific inhibitors (pages 698-701).
Original language | English |
---|---|
Pages (from-to) | 621-622 |
Number of pages | 2 |
Journal | Nature medicine |
Volume | 5 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1999 |